View drug registration information details.
| Items | Registration information |
|---|
| ID | 1707 |
|---|
| No | 1707 |
|---|
| Brand Name | LUCIDABRA |
|---|
| Ingredients | DABRAFENIB 75 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 120 CAPSULES/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | AS A SINGLE AGENT FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH BRAF V600E MUTATION. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | RED-ORANGE CAPSULE CONTAINS WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 10 L 1025/23 |
|---|
| FDD Registration Date | 10-OCT-2023 |
|---|
| Expiry Date | 09-OCT-2026 |
|---|
Back to drug list
|
